FDA Approves Two-Drug, Fixed-Dose, Complete Regimen HIV-1 Treatment
April 09, 2019
The agency approved Dovato (dolutegravir and lamivudine), as a complete regimen for the treatment of HIV-1 infection in adults with no antiretroviral treatment history and with no known or suspected substitutions associated with resistance to the individual components of Dovato.